Anne Bergeron
Overview
Explore the profile of Anne Bergeron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
2515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Genecand L, Jaksic C, Desponds R, Simian G, Guerreiro I, Thorens S, et al.
Physiol Rep
. 2025 Feb;
13(5):e70233.
PMID: 40019840
The dispersion of the tidal volume and of the breathing frequency have been used to diagnose dysfunctional breathing during cardio-pulmonary exercise testing. No validated methods to objectively describe this dispersion...
2.
Bondeelle L, Clement S, Bergeron A, Tapparel C
Eur Respir Rev
. 2025 Feb;
34(175).
PMID: 39971397
Stem cells are capable of self-renewal and differentiation into specialised types. They range from totipotent cells to multipotent or somatic stem cells and ultimately to unipotent cells. Some adult multipotent...
3.
Tran C, De Kerviler E, Bergeron A, Raffoux E, Xhaard A, de Bazelaire C, et al.
PLoS One
. 2025 Jan;
20(1):e0316459.
PMID: 39746058
Objective: Febrile neutropenia (FN) is a serious clinical event, associated with significant morbidity and mortality. Imaging has a central role in the identification of the fever cause. The study objectives...
4.
Guirriec Y, Luque-Paz D, Bernard G, Mabo A, Kerjouan M, Menard C, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39624377
Background: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease that may progress towards pulmonary fibrosis. Data about fibrosis prevalence and risk factors are lacking. Methods: In this retrospective multicentre...
5.
Sood R, Marando M, Gijs P, Balmpouzis Z, Bergeron A, Koutsokera A, et al.
Rev Med Suisse
. 2024 Nov;
20(895):2110-2115.
PMID: 39544057
Pneumocystis jirovecii (PJ), an opportunistic fungus, can have major consequences in terms of morbidity and mortality. These infections occur mainly in immunocompromised patients and are known for their pulmonary tropism...
6.
Bergeron A, Bernasconi M, Bridevaux P, Egger B, Fellrath J, Valenti A, et al.
Rev Med Suisse
. 2024 Nov;
20(895):2091.
PMID: 39544053
No abstract available.
7.
Velasquez T, El Maazi S, Bergeron A, Bosetti D, Kaiser L, Gillabert C, et al.
Rev Med Suisse
. 2024 Sep;
20(888):1714-1717.
PMID: 39323274
Community acquired pneumonia is a well-known entity in internal medicine. It represents 1.2 cases per 1000 inhabitants every year, and up to 14 cases per 100 inhabitants in people older...
8.
Bondeelle L, Huang S, Constant S, Clement S, Salmona M, Le Goff J, et al.
Pharmacol Res Perspect
. 2024 Aug;
12(5):e1242.
PMID: 39210688
Cyclosporin A (CsA), an immunosuppressive drug used in transplant recipients, inhibits graft rejection by binding to cyclophilins and competitively inhibiting calcineurin. While concerns about respiratory infections in immunosuppressed patients exist,...
9.
Philippot Q, Rammaert B, Dauriat G, Daubin C, Schlemmer F, Costantini A, et al.
Heliyon
. 2024 Jul;
10(13):e33231.
PMID: 39035530
Background: Human metapneumovirus (hMPV) is one of the leading respiratory viruses. This prospective observational study aimed to describe the clinical features and the outcomes of hMPV-associated lower respiratory tract infections...
10.
Pinana J, Cesaro S, Mikulska M, Verweij P, Bergeron A, Neofytos D, et al.
Curr Res Transl Med
. 2024 Jul;
72(3):103461.
PMID: 39032263
In 2023, the EBMT Practice harmonization and Guidelines Committee partnered with the EBMT Infection Diseases Working Party (IDWP) to undertake the task of delivering best practice recommendations, aiming to harmonize...